Boehringer Ingelheim
26 products tracked · names used in filings: Boehringer Ingelheim, Boehringer Ingelheim International GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 15 Jul 2026🇪🇺 EU approval (EC decision)
Jascayd (nerandomilast) approved in the EU
Marketing authorisation to Boehringer Ingelheim International GmbH; Additional monitoring · source
Thu 21 May 2026🇪🇺 CHMP positive opinion
Jascayd (nerandomilast): CHMP positive opinion
Boehringer Ingelheim International GmbH; Additional monitoring · source
Fri 19 Dec 2025🇺🇸 FDA approval
FDA approves Jascayd (nerandomilast): new indication (separate nda)
Boehringer Ingelheim; NDA220449; New indication (separate NDA), Priority review; tablet · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Faldaprevir Boehringer Ingelheim faldaprevir | Application withdrawn | |
| 🇪🇺 | Jascayd nerandomilast | Authorised | 2026-07-15 |
| 🇺🇸 | Jascayd nerandomilast | Approved | 2025-12-19 |
| 🇺🇸 | Jascayd nerandomilast | Approved | 2025-10-07 |
| 🇪🇺 | Cyltezo adalimumab | Withdrawn | 2017-11-10 |
| 🇪🇺 | Glyxambi empagliflozin;linagliptin | Authorised | 2016-11-11 |
| 🇪🇺 | Praxbind idarucizumab | Authorised | 2015-11-20 |
| 🇪🇺 | Synjardy empagliflozin;metformin | Authorised | 2015-05-27 |
| 🇪🇺 | Ofev nintedanib | Authorised | 2015-01-14 |
| 🇪🇺 | Vargatef nintedanib | Authorised | 2014-11-21 |
| 🇪🇺 | Jardiance empagliflozin | Authorised | 2014-05-22 |
| 🇪🇺 | Giotrif afatinib | Authorised | 2013-09-25 |
| 🇪🇺 | Jentadueto linagliptin;metformin hydrochloride | Authorised | 2012-07-19 |
| 🇪🇺 | Onduarp telmisartan;amlodipine | Withdrawn | 2011-11-24 |
| 🇪🇺 | Trajenta linagliptin | Authorised | 2011-08-23 |
| 🇪🇺 | Twynsta telmisartan;amlodipine | Authorised | 2010-10-07 |
| 🇪🇺 | Duloxetine Boehringer Ingelheim duloxetine | Withdrawn | 2008-10-08 |
| 🇪🇺 | Pradaxa dabigatran etexilate | Authorised | 2008-03-17 |
| 🇪🇺 | Aptivus tipranavir | Authorised | 2005-10-25 |
| 🇪🇺 | MicardisPlus telmisartan;hydrochlorothiazide | Authorised | 2002-04-19 |
| 🇪🇺 | Metalyse tenecteplase | Authorised | 2001-02-23 |
| 🇪🇺 | Tenecteplase Boehringer Ingelheim Pharma GmbH Co. KG tenecteplase | Withdrawn | 2001-02-23 |
| 🇪🇺 | Micardis telmisartan | Authorised | 1998-12-16 |
| 🇪🇺 | Mirapexin pramipexole | Authorised | 1998-02-23 |
| 🇪🇺 | Viramune nevirapine | Authorised | 1998-02-04 |
| 🇪🇺 | Sifrol pramipexole | Authorised | 1997-10-13 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.